These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2826285)

  • 21. [Evaluation of intermittent hepatic arterial occlusion with infusion chemotherapy of unresectable hepatocellular carcinoma].
    Naitoh A; Tarumi T; Nakase A
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):1-11. PubMed ID: 3009664
    [No Abstract]   [Full Text] [Related]  

  • 22. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A resected case of hepatocellular carcinoma effectively treated by hepatic artery embolization and systemic chemotherapy].
    Kobayashi T; Yoshida M; Araki I; Shinagawa T; Sekikawa H; Noda M
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3791-4. PubMed ID: 2556974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined hepatic arterial infusion chemotherapy with transcatheter arterial embolization and hyperthermia in primary liver cancer].
    Izumi R; Urade M; Kimura H; Kobayashi M; Yabushita K; Watanabe T; Fujimura T; Ohhori I; Itoh M; Yonemura Y
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2465-9. PubMed ID: 2843110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.
    Ikeda M; Okada S; Yamamoto S; Sato T; Ueno H; Okusaka T; Kuriyama H; Takayasu K; Furukawa H; Iwata R
    Jpn J Clin Oncol; 2002 Nov; 32(11):455-60. PubMed ID: 12499417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage.
    Huang YH; Chen CH; Chang TT; Chen SC; Chiang JH; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Huo TI; Lee SD; Wu JC
    Aliment Pharmacol Ther; 2005 Mar; 21(6):687-94. PubMed ID: 15771754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
    Vitale FV; Romeo P; Vasta F; Panebianco V; Calì S; Rotondo S; Ferraù F; La Greca M
    Anticancer Res; 2007; 27(6B):4077-81. PubMed ID: 18225574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors.
    Takayasu K; Wakao F; Moriyama N; Muramatsu Y; Yamazaki S; Kosuge T; Takayama T; Okada S; Okazaki N; Makuuchi M
    Hepatology; 1992 Oct; 16(4):906-11. PubMed ID: 1328010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].
    Kitamura T; Maruyama T; Nakamura H; Hayashi K; Shigehira M; Iwaki Y; Okamoto T; Ishikawa T; Ishinoda Y; Kisanuki H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1467-71. PubMed ID: 2167633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
    Nagamatsu H; Sumie S; Niizeki T; Tajiri N; Iwamoto H; Aino H; Nakano M; Shimose S; Satani M; Okamura S; Kuromatsu R; Matsugaki S; Kurogi J; Kajiwara M; Koga H; Torimura T
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):243-50. PubMed ID: 26754678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial.
    Kawata S; Yamasaki E; Nagase T; Inui Y; Ito N; Matsuda Y; Inada M; Tamura S; Noda S; Imai Y; Matsuzawa Y
    Br J Cancer; 2001 Apr; 84(7):886-91. PubMed ID: 11286466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical studies of intermittent hepatic artery occlusion with infusion chemotherapy--19 cases of unresectable hepatocellular carcinoma and 14 cases of metastatic liver cancer].
    Yano S; Naito A; Tarumi T; Yamamoto T; Tamura K; Nakase A
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2534-45. PubMed ID: 2559128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
    Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of intra-arterial chemotherapy with reservoir for patients with unresectable hepatocellular carcinoma].
    Yasuhara M; Une Y; Shimamura T; Misawa K; Masuko Y
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):455-8. PubMed ID: 8678497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physiologic hepatic dearterialization and 5-FU intra-arterial perfusion in primary hepatic carcinoma].
    Wang CE; Cao XH; Zhen YY
    Zhonghua Wai Ke Za Zhi; 1985 Sep; 23(9):525-7, 571-2. PubMed ID: 3004843
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined therapy with external beam irradiation and hepatic arterial epirubicin infusion through an implanted port for advanced hepatocellular carcinoma.
    Takizawa K; Honda M; Obuchi M; Hasebe S; Matsuoka S; Yamada M; Kuniyasu Y
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-116-S6-121. PubMed ID: 9151926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization.
    Akasu T; Moriya Y; Takayama T
    Jpn J Clin Oncol; 1997 Oct; 27(5):331-5. PubMed ID: 9390211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma.
    Suto T; Fukuda S; Moriya N; Watanabe Y; Sasaki D; Yoshida Y; Sakata Y
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S145-8. PubMed ID: 8137477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.